Nomura Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
GIM
Nomura Asset Management's TXG Position: Q2 2024 in Review
Nomura Asset Management sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 18,768 shares — an estimated $491K sold.
Nomura Asset Management first reported a position in TXG in Q4 2020 and held it in 14 quarters. The position peaked at $6.56M in Q4 2021. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.
- Nomura Asset Management reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
- Nomura Asset Management sold 18,768 10x Genomics shares in Q2 2024, an estimated $491K.
- Nomura Asset Management first reported a position in 10x Genomics in Q4 2020 and held it in 14 quarters.
- Nomura Asset Management's 10x Genomics position peaked at $6.56M in Q4 2021.
- 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.
Based on Nomura Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.